Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies

Thomas McKerrell(Wellcome Sanger Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Nicla Manes(Wellcome Sanger Institute), Theodora Foukaneli(Addenbrooke's Hospital), Michael A. Quail(Wellcome Sanger Institute), Jorge Sierra(Universitat Autònoma de Barcelona), Alan J. Warren(Wellcome/MRC Cambridge Stem Cell Institute), Josep Nomdedéu(Centre de Recherche Jean Pierre Aubert), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Paul Costeas(Deakin University), Thaidy Moreno-Rodriguez(Instituto de Biomedicina y Biotecnología de Cantabria), David Bloxham(University of Namur), Bram Herman(Agilent Technologies (United Kingdom)), Carolyn Grove(The University of Western Australia), E. Joanna Baxter(University of Cambridge), Niccolò Bolli(University of Milan), Mike Scott(Addenbrooke's Hospital), Bridget Manasse(National Health Service), Ignacio Varela(Wellcome Sanger Institute), Ville Mustonen(Wellcome Sanger Institute), Naomi Park(Wellcome Sanger Institute), Clare Hodkinson(University of Cambridge), João M.L. Dias(Centro Hospitalar do Porto), Roland Rad(ING Direct), Anthony J. Bench(Addenbrooke's Hospital), Zemin Ning(Wellcome Sanger Institute), Hannes Ponstingl(Wellcome Sanger Institute), Chris Tyler‐Smith(Wellcome Sanger Institute), Danielle Fletcher(Agilent Technologies (United Kingdom)), German Tischler(Wellcome Sanger Institute), Jianxiang Chi(Center for the Study of Childhood and Adolescence), Vincenza Colonna(University of Tennessee Health Science Center)
Blood
April 28, 2016
Cited by 60


Related Papers